Infratil says the market will re-rate Metlifecare
But Infratil is rationing capital for better opportunities.
Infratil says it had a disproportionate influence on Metlifecare during the three-and-a-half years it owned its near 20% stake and the sharemarket will eventually re-rate the stock because of the changes made in those years.
On Friday, Infratil announced it had sold the stake for $238 million,
Want to read more? It's easy.
Choose your best value subscription option
Individual
Group membership
NBR Marketplace
Yearly Premium Online Subscription
NZ$499.00 / yearly
Monthly Premium Online Subscription
NZ$44.95 / monthly
Smartphone Only Subscription
NZ$24.95 / monthly
Premium Group Membership 10 Users
NZ$350+GST / monthly
$35 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$600+GST / monthly
$30 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1250+GST / monthly
$25 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$1875+GST / monthly
$18.75 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$499.00 / yearly
Already have an account? Login
Jenny Ruth
Mon, 10 Apr 2017
Mon, 10 Apr 2017
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Infratil says the market will re-rate Metlifecare
66217